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A novel system for the release of neurotrophic factor into a nerve guidance channel (NGC) based      
on resorbable phosphate glass hollow fibres (50P2O5-30CaO-9Na2O-3SiO2-3MgO-2.5K2O-
2.5TiO2 mol%) in combination with a genipin-crosslinked agar/gelatin hydrogel  (A/G_GP) is 
proposed. 
No negative effects on the growth of Neonatal Olfactory Bulb Ensheathing Cell line (NOBEC) 
as well as on the expression of pro- and anti-apoptotic proteins was measured in vitro in the 
presence of fibre dissolution products in the culture medium. For the release studies, fluorescein  
isothiocyanate-dextran (FD-20), taken as growth factor model molecule, was solubilized in 
different media and introduced into the fibres lumen exploiting the capillary action. The fibres 
were filled with i) FD-20/ phosphate buffered saline (PBS) solution ii) FD-20/hydrogel solution 
before gelation iii)hydrogel before gelation, subsequently lyophilized and then filled with the 
FD-20/PBS solution. The different strategies used for the loading of the FD-20 into the fibres 
resulted in different release kinetics. A slower release was observed with the use of A/G_GP 
hydrogel. At last, poly(ε-caprolactone) (PCL) nerve guides containing the hollow fibres and the 
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1. INTRODUCTION  
 
The peripheral nerve axons can spontaneously regenerate after nerve injury thanks to the ability 
of the Schwann cells to promote a permissible environment for axonal growth [1]. In spite of this  
spontaneous regeneration, a complete recovery of nerve function after a severe lesion is unlikely 
to occur and clinical results have been, so far, unsatisfactory [2]. After peripheral nerve injuries, 
the capability of injured axons to regenerate and recover functional connections depends on the 
type of lesion and the distance over which the regenerating axons must grow to reinnervate their 
peripheral targets. After nerve crush, regeneration is usually successful, since the continuity of 
the endoneurial tubes is preserved [3]. 
In the case of more severe injuries, involving damages of the perineurium and endoneurium or 
the complete nerve transection, the spontaneous regeneration process is compromised and a 
surgical intervention becomes necessary [4]. For large nerve defects, in which direct suture of the 
two stumps (i.e. end-to-end suture) would generate excessive tension, the bridging of the gaps 
with an autologous nerve graft is currently considered the current gold standard  [4,-5]. The use 
of a nerve guidance channel (NGC) sutured in between the two nerve stumps represents an 
alternative to autograft implantation, avoiding the additional surgical procedure needed for nerve 
graft harvesting. Moreover, NGC implies a less surgical trauma due to fewer epineurial sutures, 
the absence of any interference from the imperfectly aligned autograft fascicles, the 
minimization of fibrous scar tissue infiltration and the maximization of soluble factors 
accumulation  [5]. 
Some NGCs are currently available on the market [4,6,7], but their use is limited to short nerve 
defects, up to about 3 cm [8]. For large nerve gaps, an inadequate formation of the fibrin cables 
between the two nerve stumps limits the migration of native SCs and the formation of Bands of 
Büngner, which are the trophic and topographical guidance structures for the regenerating axons 
growing from the proximal stump. Another important issue can be an insufficient neurotrophic 
support into the NGC  [9]. For these reasons, there is a need to confer additional functionalities 
to the NGCs in order to improve the regeneration of longer nerve defects. A number of 
neurotrophic factors have been shown to stimulate axonal regeneration when placed in the lumen 
of the tube. These include the nerve growth factor (NGF) [10], fibroblast growth factor (FGF) 
[11], vascular endothelial growth factor (VEGF) [12], insulin-like growth factor-I (IGF-I) [13] 
and a combination of the platelet-derived growth factor BB (PDGF-BB) and IGF-I [14]. Growth  
factors (GFs) are usually delivered via a carrier because of their limited activity in vivo; for 
instance, VEGF has a clearance half-life of less than 1 hour following injection in vivo [15]. 
Therefore, systems guaranteeing the stability and a controlled release of a GF are required in 
order to mimic the temporal presence of GFs in the biological environment. 
In a previous study, Vitale-Brovarone et al. [16] showed that phosphate glass fibres are able to  
support glial and neuronal cell adhesion and to direct the growth of long axons, showing to be 
promising for the a promising creation of topographical guidance structures for cells during 
nerve regeneration.  
Moreover phosphate glass hollow fibres could easily incorporate a liquid exploiting the capillary 
action and subsequently release it [17]. In this study, phosphate glass hollow fibres are proposed 
as a means for the incorporation and release of neurotrophic factors into a NGC. Fluorescein 
isothiocyanate-dextran (FD-20) is selected as a model molecule to study the release of 
biomolecules from the glass fibres. FD-20 is a fluorescent molecules having a Mw around 22 
kDa and a Stokes radius of 33 Å (supplier’s data) comparable to the dimensions of many relevant 
GFs in nerve regeneration (e.g., NGF VEGF, brain-derived neurotrophic factor - BDNF, glial 
cell-derived neurotrophic factor-GDNF, all having molecular weights in the range of 20–30 kDa 
as dimers) [18]. 
In order to tailor the release kinetics from the glass hollow fibres, an agar (A)/gelatin (G) 
hydrogel crosslinked with genipin (A/G_GP) is proposed as a filler for the hollow fibres. This 
hydrogel was previously described by Tonda-Turo et al. [19] as an injectable filler for NGCs.  
The mild conditions for hydrogel preparation (low temperature and physiological pH) are 
advantageous for the incorporation of bioactive molecules avoiding their denaturation, while 
hydrogel microporosity allows an efficient biomolecule delivery. 
Finally, a multifunctional NGC was fabricated filling a porous poly(ε-caprolactone) (PCL) guide 
with both glass hollow fibres and A/G_GP hydrogel. 
 
2. MATERIALS AND METHODS  
 
2.1 Hollow fibre drawing 
Phosphate glass hollow fibres (glass composition 50P2O5-30CaO-9Na2O-3SiO2-3MgO-2.5K2O-                  
2.5TiO2  mol %, Coded as TiPS2.5 [20–21]) were drawn using an in-house   developed drawingtower 
equipped with an online optical fibre diameter monitor, as previously described  [16]. In brief, 
the precursors of the glass (Sigma-Aldrich) were melted in a 90Pt/10Rh %wt crucible in a 
furnace and cast into a pre-heated (below 440°C, which is the glass transition temperature) 
stainless steel mould, subsequently rotated around its longitudinal axis (3400 rpm) using an 
homemade rotational equipment (no load motor, 50W). A cylindrical glass hollow preform 
(outer and inner diameter, Dpo= 11.3 mm and Dpi=6.5 mm, respectively 11.3 mm) was obtained 
and then annealed (410°C, 15 h). The preform was heated at 610 °C in the drawing tower 
causing the formation of a neck-down region with the creation of a thin fibre which was 
collected on a rotating drum. Acting on the preform feeding speed, vp, and the fibre speed, vf, it 
was possible to obtainn two type of fibres (coded as FA and FB) with different  diameters (Table 
1). The theoretical fibre outer (TDfo) and inner (TDfi) diameters were calculated imposing the mass 
conservation law and the retention of the outer to inner diameter ratio of the hollow preform (R= 
Dfo/ Dfi = Dpo/Dpi = 1.74) using the following formulas: 
(1) TDfo = Dpo√(vp/vf)  
(2) TDfi = TDfo/R  
The fibres were observed using an optical microscope and the outer and inner diameters (Dfo and 
Dfi) of the obtained fibres were measured on 20 fibre sections by image processing (Image J 
software). 
 
2.2 Biological test with the fibre dissolution products 
 
The effect of the fibre dissolution products was studied on Neonatal Olfactory Bulb Ensheathing 
Cell line (NOBEC), derived from primary cells dissociated from neonatal rat olfactory bulb and 
immortalized by retroviral transduction of SV40 large T antigen [22]. 
Two samples of hollow fibres (FB, 2 cm) were sterilized in an oven (180°C, 3 h), soaked in 
Dulbecco's Modified Eagle Medium (DMEM; Sigma-Aldrich) supplemented with 100 units ml
-1
 
penicillin, 0.1 mg ml
-1
 streptomycin, 1 mM sodium pyruvate, 2 mM L-glutamine and 10% heat-
inactivated fetal bovine serum (FBS; all from Invitrogen) at a (solution volume)/(fibre exposed 
surface) ratio of 1 ml/cm
2
 and stored at 37°C in a humidified atmosphere of 5% CO2/air. 
Moreover, it was verified that the heat sterilization process (180°C, 3 h) do not interfere with the 
possibility of filling the hollow fibres. 
At different time points (3, 14, 21 and 28 days) the medium was collected and the fibres were 
washed in distilled water, dried in an oven at 37°C and weighed. The weight loss percentage at 
the time point i was calculated using the following formula: 
(3) %WLi = 100 (W0-Wi)/W0 
where W0 and Wi are, respectively, the sample weight at the beginning of the test and at the time 
point i. 
The weight loss rate per unit area (WLR) was calculated dividing the final weight loss (WL) of 
the samples at the end of the test by the test duration t and by the exposed surface area A, which 
was approximated as the inner and outer lateral surface of an hollow cylinder of length L and 
inner and outer diameter equal to Dfi and Dfo: 
(4) WLR = WL/(tA) = WL/ [tπL (Dfo + Dfi)] 
In order to evaluate the dissolution products effects on cells, a proliferation cell curve was 
carried out with media collected after 14 and 28 days of fibre dissolution (sample code, 
respectively 14F, 28F). As control media, samples of culture medium without fibres were 
maintained in the same conditions of the fibre-containing samples and then collected after 14 and 
28 days (“aged” media, ctrl14, ctrl28). For each test also “fresh” culture medium (ctrl) was used. 
The media (14F, 28F, ctrl14, ctrl28) were supplemented with 100 units ml
-1
 penicillin, 0.1 mg 
ml
-1
 streptomycin, 1 mM sodium pyruvate, 2 mM L-glutamine and 10% heat-inactivated fetal 
bovine serum (FBS; all from Invitrogen) before in vitro tests. About 2000 cells/cm
2
 were 
cultured in a 12-well plate in the presence of 1 ml of the media containing the fibre dissolution 
products (14F) and the control media (ctrl, ctrl14). After 1, 3 and 5 days of incubation, the cells 
were washed with phosphate buffered saline (PBS; Invitrogen) and detached by incubation with 
500 µl of trypsin (Sigma-Aldrich) for 5-10 min at 37°C. Complete medium was added to 
inactivate trypsin and then cells were counted using a Bürker’s chamber. The study was carried 
out in triplicate and reported as mean value ± standard error of the mean. 
About 27000 cells/cm
2
 were cultured in a 12-well plate in the presence of 1 ml of the medium 
containing the fibre dissolution products (28F) and the control media (ctrl, ctrl28). After 3 days 
of culture total proteins were extracted from 3 different wells by solubilizing cells in boiling 
Laemmli buffer (2.5% SDS and 0.125 M Tris-HCl pH 6.8), followed by 3 min at 100°C. Protein 
concentration was determined by the bicinchoninic acid assay (BCA) method, and equal amounts 
of proteins (denaturated at 100°C in 240 mM 2-mercapto ethanol and 18% glycerol) were 
separated on a 12% polyacrylamide gel, consisting of Acrylamide-bisacrylamide 12%; 0.375M 
Tris pH 8.8, 0.1% SDS, 0.1% ammonium persulfate and tetramethylethylenediamine (TEMED)  
0.06%, to which was applied a voltage of 150 volts for approximately 2 hours. The protein gel 
was subjected to transfer on a nitrocellulose membrane and blocked for 1 h at 37 °C in 1X TBST 
(150 mM NaCl, 10 mM Tris-HCl (pH 7.4), and 0.1% Tween) plus 5% non-fat milk. The 
membranes were incubated overnight at 4 °C in primary antibodies: anti-Bcl-XL (Santa Cruz) 
diluted 1:500, anti-Bax (Santa Cruz) diluted 1:500 in TBST plus 1% non-fat milk. The next day, 
they were rinsed four times with TBST for 5 min each at room temperature and incubated for 1 h 
at room temperature with horseradish peroxidase-linked anti-mouse (1:10,000) secondary 
antibody (diluted in TBST plus 1% non-fat milk). Membranes were washed 4 times, 5 min each, 
with TBST at room temperature, and specific binding was detected by the enhanced 
chemiluminescence ECL system (Amersham Biosciences) using HyperfilmTM (Amersham 
Biosciences). 
 
2.3 Hydrogel preparation 
 
The genipin crosslinked agar/gelatin hydrogel (A/G_GP) was prepared as described elsewhere  
[19]. In brief, A (Sigma Aldrich) was dissolved in PBS at 90°C in an oven for 1 hour to obtain a 
0.4 % (wt./vol.) solution. The solution was kept under magnetic stirring at 50°C for 30 minutes. 
G (type A from porcine skin, Sigma Aldrich) was added to obtain a A/G 20/80 wt./wt. solution 
2% wt./vol., which was kept under magnetic stirring at 50°C for 30 minutes. Finally, GP was 
added to the A/G solution at a 2.5% wt./wt. amount with respect to the total amount of A and G. 
The resulting A/G_GP solution was kept under magnetic stirring at 50°C for 30 minutes and 
used as described in the next paragraphs. 
 
2.4 Study of FD-20 release from the hollow fibres 
 
Different release studies were carried out from the hollow fibres using FD-20 (Sigma Aldrich) as 
a model molecule. FD-20 was solubilized in PBS or was loaded into the A/G_GL hydrogel prior 
to gelification and introduced into the fibres lumen exploiting the capillary action following 
different strategies. The different samples used for the release studies are summarised in Table 2. 
Different fibres and filling procedures were applied to evaluate their influence on biomolecules 
release. 
For the first set of experiments, the influence of inner and outer fibre diameters and fibre length 
on FD-20 release was analysed. FA fibres of 2 cm and FB fibres with different length (1.5, 2 and 
2.5 cm) were filled with a FD-20/PBS solution (10 mg/ml) exploiting the capillary action by 
soaking one of the fibre bundle extremities into the solution (sample codes, respectively, FA-2, 
FB-1.5, FB-2, FB-2.5). 
For the second set of experiments, samples of FB fibres with a length of 2 cm were filled with 
FD-20-containing hydrogel - (sample code FB-2-H). The hydrogel were prepared as described in 
paragraph 2.3 and FD-20 was added into the A/GL_GP solution (10 mg/ml) prior to gelification. 
The fibres  were then filled with the FD-20/hydrogel solution before gelification exploiting the 
capillary action as described before. Fibres were kept at room temperature until hydrogel 
gelification occurred and then stored at 4°C until they were used for the release study. 
For the last set of experiments, FB fibres with a length of 2 cm were filled with the  
A/G_GP solution before gelification, kept at room temperature until hydrogel gelification 
occurred, frozen at -20°C for 24 hours and then lyophilized using a SCANVAC Coolsafe 5P 
freeze dryer. Finally, the cavity of the fibres, containing a porous matrix of lyophilized hydrogel, 
was filled with a FD-20/PBS solution (10 mg/ml) exploiting the capillary action (sample code 
FB-2-LH). The sample morphology resulting from different filling procedures (FA-2, FB-1.5, 
FB-2, FB-2.5; FB-2-H, FB-2-LH) was observed using an optical microscope (Nikon Optishot 
Microscope). 
To study the FD-20 release profile of the different FD-20-containing fibres, fibres of each type 
(FA-2, FB-1.5, FB-2, FB-2.5, FB-2-H and FB-2-LH, table 2) were soaked in PBS ((solution 
volume)/(fibre exposed surface) of 1 ml/cm
2
) into a flask and stored at 37°C. 5 ml of medium 
was taken at different time points until no further change in FD-20 concentration was observed 
(1, 5, 22, 24, 48 h for FA-2, FB-1.5, FB-2 and FB-2.5; 1, 5, 24, 31, 48, 72, 144, 168, 192 h for 
FB-2-H; 1, 5, 24, 31, 48, 72, 144 h for FB-2-LH). The medium was analysed using UV-Vis 
spectrophotometer (Cary 500 Varian) for absorbance measurement (FD-20 main absorbance 
peak at 490 nm) and then replaced into the flask. The glass dissolution products derived from the 
fibre dissolution in PBS caused the presence of a peak at about 250 nm in the UV-Vis absorption 
spectrum showing increasing amplitude with time, which interfere with the FD-20 peak. For this 
reason, the UV-Vis spectrophotometer calibration curves were derived at each time points using 
FD-20/PBS solutions (6.25, 12.5 25, 50, 100 µg/ml) containing samples of glass fibres, prepared 
and stored in the same conditions used for the samples of the release test ((solution 
volume)/(fibre exposed surface) of 1ml/cm
2
, stored at 37°C). Moreover, a refresh of the medium 
was carried out twice a week for the samples requiring longer soaking time (FB-2-H and FB-2-
LH). 
For each sample, the FD-20 release percentage at the time point i was calculated using the 
following formula: 
(5) %Releasei = 100Ci/Cmax ,where Cmax and Ci are, respectively, the maximum FD-20  
concentration measured at the end of the test (i.e. when all FD-20 had been released) and the FD-
20 concentration measured at the time point i. For the measures performed after medium refresh, 
Ci was calculated as the sum of the concentration measured at the time point i and those 
measured before the refresh. The release percentage is reported as mean value and standard 
deviation for each type of sample. 
The release profile curves were interpolated on the basis of the semi-empirical power law 
(6) Mi/M∞ = Kt
n
 
and the Weibull function: 
(7) Mi/M∞ = 1-exp(-at
b
), 
in which  Mi and M∞ are, respectively, the amount of FD-20 released at time t and at infinite time, 
k is the kinetic constant. The n parameter depends on the geometry of the system and on the drug  
release mechanisms (equation 6), while a and b are constants (equation 7) [23,-24]. 
In terms of concentration and % release, equation 6 and 7 can be rewritten as: 
(8) Ci/Cmax=%Releasei /100 = Kt
n
  ,  
(9) Ci/Cmax=% Releasei /100 =1-exp(-at
b
).  
Since the semi-empirical power law is a short time approximation (Mi/M∞<0.6)  [23], the 
interpolation with equation 8 was limited to the first 60% of the release curve, while equation 9 




2.5 Feasibility and morphological evaluation of multifunctional nerve guidance channel 
 
Poly(ε-caprolactone) (PCL) porous tubes were obtained as described elsewhere [25]. Briefly, a 3 
mm stainless steel rotating mandrel (diameter 3 mm) was dipped into PCL / polyethylene oxide 
(PCL/PEO, 60/40 wt./wt.) solution, left air-dried for 12 hours and, then, immersed in PBS for 2 
days  to remove PEO and obtain a porous wall structure. The tubes were cut to obtain samples of 
1.5 cm of length. A bundle of hollow fibres (FB, 1.5 cm length, about 120 mg) filled with the 
hydrogel (as described at paragraph 2.4) was inserted into the PCL tube. Finally, the hydrogel 
was injected before gelification with a pipette in order to completely fill the tube lumen. The 
PCL tube/glass hollow fibres system was kept at ambient temperature until hydrogel gelification. 
The morphology of the resulting guide was analysed using a scanning electron microscope 
(SEM; Quanta Inspect 200LV, Fei Company, The Netherlands). For the analysis the guide was 
embedded in epoxy resin (Epofix, Struers) and cut by a diamond disc saw (Struers Accutom 5, 
cut-off wheel 330CA) to obtain a section. The guide was also analysed by X-ray absorption 
microtomography (µCT, SkyScan 1174v2, SkyScan N.V., Kontich, Belgium) to obtain a three-
dimensional image of the structure of the guide (50kV, 880 µA, exposure time 1900 s, pixel size 
6.5 µm). 
 
3. RESULTS AND DISCUSSION 
 
3.1 Hollow fibres 
 
The inner and outer fibre diameters of the hollow glass fibres (Dfi and Dfo) were 69 ± 5 µm and 
121 ± 4 µm for FA and 94 ± 3 and 167 ±4 µm for FB, respectively. These values are in 
agreement with the theoretical ones (Table 3). 
 
3.2 Biological test with the fibre dissolution products 
 
Results of dissolution study for the hollow fibres (FB, 2 cm) soaked in culture medium are 
reported in Fig.ure 1. A weight loss percentage (%WL) of 14% ± 4% after 28 days (Fig. 1), 









measured. The values obtained are of the same order of magnitude, but slightly lower, than those 









). The slower dissolution of TiPS2.5 glass in culture medium 
probably due to the presence of serum proteins and of some ions in solution, like Ca
2+
, which 
are known to hinder the glass dissolution [21,26]. 
The media containing the fibre dissolution products were used for in vitro test to study their 
influence on NOBEC cells. The proliferation curves of NOBEC cells incubated with media 
containing the fiber dissolution products after 14 days of dissolution (14F) and the control media 
(ctrl, ctrl14) are reported in Fig. 2. 
No significant differences between all experimental groups (ctrl, ctrl14, 14F) were observed after 
1, 3 and 5 days of culture,showing that dissolution products did not influence cell survival and 
proliferation. 
In order to verify the absence of a cytotoxic effect of dissolution products, ctrl, ctrl28 and 28F 
samples were analyzed by Western blot for apoptotic proteins expression after 3 days of culture. 
Bax, a cytosolic protein that plays a pro-apoptotic role, and Bcl-xl, a pro-survival protein, have 
the same expression in ctrl, ctrl28 and 28F (Fig. 3). 
 
3.3 Study of FD-20 release from the hollow fibres 
 
In this study, the use of phosphate glass hollow fibres for the release of FD-20, as model 
molecule for growth factors such as NGF, VEGF, BDNF, GDNF was studied. The possibility of 
tailoring the FD-20 release kinetics was investigated acting on different strategies for molecule 
encapsulation (paragraph 2.4, table 2). 
As previously demonstrated, phosphate glass hollow fibres can be easily and quickly filled with 
a liquid solution exploiting the capillary action by soaking one of the fibre extremities into the 
solution  [17]. Using this procedure, the FD-20/PBS solution was used to fill the glass hollow 
fibres (Fig. 4a). The same procedure was applied to fill the hollow glass fibres with a FD-
20/hydrogel solution before gelification (Fig. 4b). Another approach consisted in filling the fibre 
with the hydrogel alone followed by a lyophilisation to produce a porous hydrogel matrix into 
the fibre lumen (Fig. 4c). The presence of the lyophilized hydrogel did not hinder filling these 
fibres with a FD-20/PBS solution by capillary action later on (Fig. 4d). 
All the described strategies were successful in filling the fibres, as desired. 
The FD-20 release from hollow fibres was studied by varying different parameters, such as fibre 
size and method for incorporation of FD-20 into the fibre lumen. 
Fig. 5 shows the FD-20 release percentage from fibres filled with FD-20/PBS (FA-2, FB-1.5, 
FB-2, FB-2.5). All the fibre types released more than 95% of FD-20 in the first 24h. Since the 
release of FD-20 is associated to a diffusion process of the molecule out of the fibres from the 
open ends, it would be expected, by the same Dfi (FB-1.5,FB-2, FB-2.5), a slower release for 
fibres with greater length L, as observed by Hong et al. [27]. Kosmidis et al.  [24] observed that  
the release kinetic is connected to the specific leak surface, that is the ratio between the area 
available for the molecule release (1/4·πDfi
2
 in this case), and the volume containning the 
molecule (i.e. 1/4·πDfi
2
·L in this case), with faster release for a higher specific leak surface. 
Thus, longer hollow fibres would show lower specific leak surface (i.e. 1/L in this case) and then 
slower release kinetics. However, even if the mean values show this trend at 1 and 5 h (FB-1.5 > 
FB-2 > FB-2.5), they did not present a statistically significant difference (one way ANOVA, 
p<0.05).  
Moreover, also different Dfi (FA-2 and FB-2) did not influenced the release kinetics in a 
statistically significant manner. 
Since fibre size did not influence the release of FD-20, the sample coded as FB-2 (table 2)  
having Dfi = 94 ± 3, Dfo= 167 ± 4 and length of 2 cm was selected to compare the FD-20 release  
using different filling procedures. 
Fig. 6 shows the release profile from fibres of identical size (inner diameter and length) loaded 
with FD-20 using different strategies (FB-2, FB-2-H, FB-2-LH). The use of A/G_GP hydrogel 
both in the hydrated and lyophilized state as hollow fibre filler alloweda slower release compared 
to fibres filled with the FD-20/PBS solution. The fibres filled with FD-20/hydrogel (FB-2-H) 
showed a complete release after 168 h, while those containning the lyophilized hydrogel and 
filled with FD-20/PBS solution (FB-2-LH) showed a complete release already after 72 h. 
The solubilisation of the FD-20 into the A/G_GP solution prior to gelification (FB-2-H) allowed 
FD-20 encapsulation inside the hydrogel obtaining a prolonged release; an initial burst release 
(36±4%) from the surface of the hydrogel is followed by a sustained release stage of FD-20 
contained into the hydrogel mesh.  
On the other hand, FB-2-LH samples showed a significantly higher burst release (52±6%)  
compared to FB-2-H because of the presence of the FD-20/PBS solution filling the 
interconnected macropores of the lyophilized hydrogel. Consequently, the leakage of FD-20 
from the fibres is made easier. The prolonged release observed after the initial burst release can 
be ascribed to the penetration of the FD-20 inside the hydrogel after PBS absorption during 
hydrogel swelling. About 45% of FD-20 was entrapped into the lyophilized hydrogels and 
slowly released afterwards. 
In order to have a better insight into the release mechanism associated to the different FD-20-
loaded hollow fibres, the interpolation of all the release data was carried out on the basis of the 
semi-empirical power law for the initial 60% of the release curve and the Weibull function 
(equation 6 and 7). The regression curve of FB-2, FB-H and FB-2-HL are represented in Fig. 7a-
b, in which the values of the parameters n, a and b are also reported. The regression curves of 
FB-1.5 and FB-2.5 are not reported since they were very similar to those of FB-2 and would 
overlap in the graph. The value of n in the semi-empirical power law is related to the geometry 
of the system and the release mechanism. For example, in thin film geometries, n is 0.5 for pure 
Fickian diffusion and 1 for swelling-controlled release mechanism [28]. Papadopoulou et al.  
[23] interpolateed the drug release from several available data using the power law (initial 60% 
of release) and the Weibull function (entire release data) and then performed a linear regression 
on the obtained n and b values. They showed that exponent b of the Weibull function is linearly 
related to n. As observed in Fig. 8 the obtained value of n and b for the different FD-20 releasing 
 hollow fibres are in accordance with the linear regression curve (dotted line) obtained by 
Papadopoulou et al.  [23]. They also found that the value of b is related to the mechanism of drug 
transport. For the diffusion in normal Euclidian space, they found b values in the range 0.69-
0.75, which is very close to that found in this work for the release from hollow fibres filled with 
FD-20/PBS (0.65 ± 0.07 to 0.82 ± 0.12). The lower values of b found for the other samples (0.54 
±0.08 for FB-2-H and of 0.49 ± 0.04 for FB-2-LH) can be ascribed to the presence of the 
hydrogel. In fact, a decrease of b reflects an increase of the disorder of the medium in which the 
Fickian diffusion takes place (e.g. in the case of fractal or disordered substrate)  [23]. 
The presence of A/G-GP hydrogel both in the hydrated and lyophilized state influenced the FD-
20 release and reduced its mobility compared to PBS by increasing the density and the structural 
complexity of the material/medium in which FD-20 was entrapped. In fact, in FB-2-H and FB-2-
LH samples, the diffusion of FD-20 is mediated by the presence of the hydrogel in different 
forms. Compared to PBS, the addition of FD-20 into lyophilized hydrogels allowed a longer 
release even after an initial FD-20 burst release. The use of FD-20 pre-loaded hydrogels (FB-2-
H) allowed to significantly reduce the burst release and to maintain a prolonged release (until 
168h). 
 
3.4 Feasibility and morphological evaluation of multifunctional nerve guidance channel 
 
Fig. 9 shows the SEM micrograph and µCT images of the fabricated nerve guide composed of a 
PCL tube containing A/G_GP hydrogel and aligned hollow glass fibres. The fibres were 
homogeneously dispersed into the guide lumen. The presence of the fibres creates an anisotropic 
structure mimicking the peripheral nerve topography.  
Furthermore, the presence of the hydrogel inside and outside the fibres allows the incorporation 
of neurotrophic factors, which would be released after implantation. Neurotrophic factor are 
released from the tube ending site guaranteeing to immediately reach the two nerve stumps 
avoiding risk of factor denaturation or leakage. The developed device combines both 
topographical and chemical factors acting as directional cues that are known to enhance the axon 
regeneration [29]. Moreover, the different strategy of fibres filling described in this work would 
allow to tailor the release kinetics of the chemical factors reaching a prolonged release with 
benefits for the regeneration process. 
 
4. CONCLUSIONS  
 
Tailoring the kinetics to achieve a sustained release of growth factors during regeneration 
process is an important issue in designing scaffolds for tissue regeneration. In a previous work, it 
was shown that phosphate glass hollow fibres are an effective mean for the incorporation and 
release of biomolecules  [17]. The possibility to tailor the biomolecules release by varying the 
filling procedures of the glass fibres for FD-20 loading was demonstrated in this work. While the 
use of a FD-20/PBS solution as fibre filling material resulted in a fast FD-20 release (i.e. about  
95% in the first 24 hours), the use of A/G_GP hydrogel as fibre filling material, allowed a slower 
FD-20 release. In fact, the higher density and structural complexity of the hydrogel is the cause 
of a reduction of FD-20 mobility compared to PBS. In particular, the fibre filled using FD-
20/hydrogel showed a slow release (i.e. complete release after 168 h), while those containing 
lyophilized hydrogel subsequently filled with FD-20/PBS solution showed an intermediate 
release rate (i.e. complete release after 72 h). 
This novel phosphate glass hollow fibres-A/G_GP hydrogel system can be used to impart both 
topographical and trophic functionalities to NGC. The fibres create an anisotropic structure 
inside the NGC which can support the adhesion of glial and neuronal cells and direct the axonal 
 
growth. Moreover, the fibre lumen can be exploited for the incorporation of  biomolecules, 
which can be then released at the tube ends to stimulate and direct the axonal regeneration after 
injuries. 
The mild conditions used for A/G_GP hydrogel preparation guarantees the GFs bioactivity even 
after encapsulation into the hydrogels. Future works will be performed to load neurotrophic GFs  
and analyze the release and  its effect in vivo. 
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Fig. 1. Weight loss percentage (%WL) of the fibre samples (FB, 2 cm) soaked in culture medium 
at a (solution volume)/(fibre exposed surface) ratio of 1 ml/cm
2
 and stored at 37°C in a 
humidified atmosphere of 5% CO2/air (mean value± standard deviation). 
 
Fig. 2. Cell counts (mean value ± standard error of the mean) obtained for NOBEC cells 
incubated with “fresh” medium (ctrl), 14 days “aged” medium (ctrl14) and the medium 
containing the fibre dissolution products after 14 days of dissolution (14F). 
 
Fig. 3. Results of Western blot analysis after incubation of NOBEC cells with “fresh” medium 
(ctrl), 28 days “aged” medium (ctrl28) and the medium containing the fibre dissolution products 
after 28 days of incubation (28F). 
 
Fig. 4. Optical micrographs showing hollow fibres filled with a) FD-20/PBS solution (FA-2 
samples), b) FD-20-containing hydrogel (FB-2-H samples) and c) lyophilized hydrogel before 
and d) after filling with FD-20/PBS solution (FB-2-LH samples). 
 
Fig. 5. FD-20 release percentage (mean value ± standard deviation) from fibres filled with a FD-
20/PBS solution (10 mg/ml). Samples: FA fibres (Dfi 69 µm) of 2 cm (FA-2), FB fibres (Dfi 
94 µm) of 1.5 cm (FB-1.5), 2 cm (FB-2) and 2.5 cm (FB-2.5). 
 
Fig. 6. FD-20 release percentage (mean value ± standard deviation) from FB fibres (Dfi  94 
µm) of 2 cm filled with FD-20/PBS solution (FB-2), FD-20-containing hydrogel (FB-2-H) and 
with lyophilized hydrogel and FD-20/PBS solution (FB-2-LH). 
 
Fig. 7. Regression curves obtained with the interpolation of the release data a) with equation 8 
(first 60% of the release curve) derived from the semi-empirical power law (equation 6) and b) 
with equation 9 (entire release data), derived from the Weibull function (equation 7). 
 
Fig. 8. Representation of n versus b parameter estimated for each type of samples. Dotted line is 
the linear regression curve (b= 
1.489n+0.0516) calculated by P 
apadopoulou et al.  [23] from the estimated values of n and b for several experimental and 
published drug release data. 
 
Fig. 9  Nerve guide composed of a PLC tube containing alignes hollow glass fibers filled with 
A/G GP hydrogel a) SEM micrograph (transverse section). X-ray absorption microtomography 
images b) of a transversal section c) of the entire guide in a threedimensional view and d) of the 
aligned hollow fibers contained into the guide lumen. 
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Table 1. Preform feeding speed (vp) and fibre speed (vf) used for fibre drawing with the 
 
corresponding theoretical inner (TDfi) and outer (TDfo) diameters of the fibres. 
 
Fibre code Vp (mm/min) Vf (m/min)  TDfi (µm)  TDfo (µm) 
       
FA 0.3 2.5 71  124  
       
FB 0.5 2.5 92  160  
 
 
Table 2. Samples used for the FD-20 release study from the glass hollow fibres 
 
Sample code Fibre type Fibre length (cm) Fibre filler 
 
     
FA-2 FA 2  
 
     









FB-2.5  2.5  
 
FB-2-H FB 2 A/G_GP/FD-20 
 
FB-2-LH FB 2 Lyophilized A/G_GP + FD-20/PBS solution 
 
 
Table 3. Measured inner and outer diameters (Dfi, Dfo) of the obtained fibres compared to the 
 
theoretical ones (TDfi, TDfo) 
 
 Theoretical diameters (µm) Measured diameters (µm) 
Fibre code  TDfi  TDfo   Dfi  Dfo 
FA 71  124  69 ± 5 121 ± 4 
FB 92  160  94 ± 3 167 ± 4 
             
 
